FTY720 Pharmacokinetics in Mild to Moderate Hepatic Impairment

The influence of mild and moderate hepatic impairment on FTY720 pharmacokinetics was assessed. The authors enrolled 32 subjects consisting of 8 with mild and 8 with moderate hepatic impairment based on Child‐Pugh criteria and 16 demographically matched control subjects. A single 1‐mg oral dose of FT...

Ausführliche Beschreibung